EUVIMEDEUVIMED entdecken
Open Access

Targeting KIR as a novel approach to improve CAR-NK cell function

Lara V Graham, Jack G Fisher, Salim I Khakoo, Matthew D Blunt iD

Journal of Translational Genetics and Genomics · 05.12.2023 · 7 (4) · 230-235

DOI: 10.20517/jtgg.2023.25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Translational Genetics and Genomics, online erschienen am 05.12.2023. Verfasst von Lara V Graham und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical and Experimental Sciences, University of Southampton, Southampton SO16 6YD, UK. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Cancer Research UK, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor (CAR) NK cells are demonstrating promising activity in clinical trials and possess a favorable safety profile compared to CAR-T cells. The Killer cell Immunoglobulin-like Receptors (KIR) have a critical role in the control of NK cell function, and recently, this family of activating and inhibitory receptors have been targeted to improve CAR-NK function. These strategies include the utilisation of inhibitory KIR to reduce trogocytosis-associated NK cell fratricide, the downregulation of inhibitory KIR on CAR-NK cells to alleviate HLA mediated suppression, the selection of CAR-NK cell donors enriched for activating KIR, and the use of activating KIR intracellular domains within novel CAR constructs. These pre-clinical studies demonstrate the potential utility of targeting the KIR to improve CAR-NK cell efficacy and patient outcomes.

Schlagwörter

Stichwörter der Autor:innen

CAR-NK cellsKiller immunoglobulin-like receptors (KIRs)chimeric antigen receptor (CAR)immunotherapynatural killer cells (NK cells)

Autor:innen und Institutionen

  • School of Clinical and Experimental Sciences, University of Southampton, Southampton SO16 6YD, UK.

ORCID-Profile: Matthew D Blunt

Förderung

  • Cancer Research UK
  • Medical Research Council

Zitieren

APA

Graham, L. V., Fisher, J. G., Khakoo, S. I., & Blunt, M. D. (2023). Targeting KIR as a novel approach to improve CAR-NK cell function. Journal of Translational Genetics and Genomics, 7(4), 230-235. https://doi.org/10.20517/jtgg.2023.25

Vancouver

Graham LV, Fisher JG, Khakoo SI, Blunt MD. Targeting KIR as a novel approach to improve CAR-NK cell function. Journal of Translational Genetics and Genomics. 2023;7(4):230-235. doi:10.20517/jtgg.2023.25

BibTeX
@article{Graham2023,
  author = {Graham, Lara V and Fisher, Jack G and Khakoo, Salim I and Blunt, Matthew D},
  title = {Targeting KIR as a novel approach to improve CAR-NK cell function},
  journal = {Journal of Translational Genetics and Genomics},
  year = {2023},
  volume = {7},
  number = {4},
  pages = {230--235},
  doi = {10.20517/jtgg.2023.25}
}
Kostenlos starten →